Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for WDB Coco Co., Ltd. (7079:JPX), powered by AI.
WDB Coco Co., Ltd. is currently trading at ¥2,560. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for WDB Coco Co., Ltd. on Alpha Lenz.
WDB Coco Co., Ltd.'s P/E ratio is 6.7.
“WDB Coco Co., Ltd. trades at a P/E of 6.7 (undervalued) with strong ROE of 23.2%. 3Y revenue CAGR of 13.8% highlights clear growth momentum.”
Ask for details →WDB Coco Co., Ltd. is a Japanese company engaged primarily in the pharmaceutical sector, focusing on the development, production, and distribution of pharmaceutical products. With a commitment to advancing healthcare solutions, WDB Coco Co., Ltd. plays a vital role in the medical industry by providing essential products that cater to a variety of therapeutic needs. The company operates in a market characterized by strict regulatory standards and an ever-evolving demand for innovative medical solutions. Its contributions are particularly significant in addressing the requirements of both healthcare providers and patients, ensuring access to effective medications. As part of the broader pharmaceutical landscape in Japan, WDB Coco Co., Ltd. is instrumental in supporting the nation's healthcare infrastructure. The company’s activities reflect a strong focus on research and quality assurance, aligning with the industry's objectives to enhance patient care and meet the dynamic challenges of global health needs.
“WDB Coco Co., Ltd. trades at a P/E of 6.7 (undervalued) with strong ROE of 23.2%. 3Y revenue CAGR of 13.8% highlights clear growth momentum.”
Ask for details →WDB Coco Co., Ltd. (ticker: 7079) is a company listed on JPX in the Healthcare sector (Health Information Services). It has approximately 566 employees. Market cap is $6.2B.
The current price is 2,560 with a P/E ratio of 6.74x and P/B of 1.43x.
ROE is 23.23% and operating margin is 24.52%. Annual revenue is $5.3B.